The findings of a new research study increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies aimed at a pathogen that causes about half a million infections in the U.S. each year.

The milestone creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program.

A new study will use innovative methods developed at VUMC to look for drugs already approved for other uses that could potentially be repurposed to treat Alzheimer's.

The award is presented to an individual who provides exemplary service and support to emergency medical services in Tennessee.

The approach will address “bottlenecks” that slow the traditional antibody discovery process, and it aims to make it possible to generate monoclonal antibody therapies against any target of interest.

One of two commonly used oximetry devices failed to detect low oxygen levels in 7% of patients with the darkest skin tone.

The milestone surgery resulted from collaboration and exemplifies a generational shift taking place in pediatric surgery.